Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis

Table 1

Upregulated and downregulated DEGs.

DEGs	Gene name
Upregulated	ACSL4, ANLN, ASPM, BUB1, BUB1B, CCNB1, CCNB2, CDC20, CDC6, CDK1, CDKN3, CENPF, CKS2, CRNDE, CTHRC1, DLGAP5, DTL, ECT2, GINS1, GPC3, IGF2BP3, KIAA0101, KIF20A, MAD2L1, NCAPG, NDC80, NUF2, PBK, PEG10, PRC1, RACGAP1, RRM2, SULT1C2, TOP2A, TPX2, TTK, UBE2C, UBE2T
Downregulated	AADAT, ACSM3, ADH1B, ADH1C, AGXT2, AKR1D1, ALDH8A1, ALDOB, APOF, BCHE, CFHR3, CFHR4, CFP, CLEC1B, CLEC4G, CLEC4M, CLRN3, CNDP1, CRHBP, CXCL2, CYP1A2, CYP26A1, CYP2B6, CYP2C9, CYP2C19, CYP2C18, ESR1, FCN2, FCN3, GBA3, GNMT, GYS2, HAMP, HAO2, HGFAC, KCNN2, KLKB1, KMO, LCAT, MARCO, MASP2, MT1E, MT1F, MT1G, MT1H, MT1M, MT1X, NAT2, OIT3, PBLD, PCK1, PGLYRP2, PLG, SLC22A1, SLC25A47, STAB2, THRSP, TMEM27, TTC36, VIPR1, XDH

99 DEGs were identified from the three profile datasets, including 38 upregulated genes and 61 downregulated genes in the HCC tissues compared with the normal controls. The bold genes are hub genes. DEGs: differentially expressed genes.